• Regulatory NewsRegulatory News

    Congress Considers Priority Review Vouchers for Medical Countermeasures

    Members of the House Energy and Commerce Oversight and Investigations subcommittee were briefed on recommendations at a hearing Friday for improving the nation's biodefence strategy against natural and man-made threats. The recommendations are particularly timely as legislators and public health officials scramble to mount a response to the Zika virus outbreak across Latin America and the Caribbean. Many of these recommendations come from the Blue Ribbon Study Panel on ...
  • FDA Guidance Clarifies Intent of Bioterrorism Law Affecting Dietary Supplements

    The US Food and Drug Administration (FDA) has released a new guidance document intended to clarify elements of a 2002 law passed in the hopes of better allowing the agency to deal with bioterrorism concerns. Background The Public Health Security and Bioterrorism Preparedness and Response Act (PHSBPR) of 2002 was passed months after a series of terror attacks hit the US in 2001. While airborne attacks on the World Trade Center buildings and the Pentagon are almost un...
  • US Bioterrorism Countermeasures Run in to Regulatory, Ethical Hurdles

    The United States has been working to develop countermeasures to potential biological terror attacks on U.S. soil and abroad.  In response to the anthrax attacks of 2001 and later simulations by the National Security Council and Johns Hopkins University that estimated that a coordinated smallpox attack could kill up to one million U.S. citizens, the Department of Defense started the Transformational Medical Technologies Initiative in 2006 to develop what it refers to...